80 likes | 99 Views
The report highlights the trends prevalent in the global interventional neuroradiology market and the factors driving the market along with those that act as deterrents to its growth.<br><br>Get sample PDF copy: https://www.theinsightpartners.com/sample/TIPRE00003497/
E N D
Interventional Neuroradiology Market Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product (Neurovascular Embolization & Coiling Assist Devices, Accessories); Disease (Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Intra-Cranial Tumors, Others); End User (Hospitals, Ambulatory Surgical Centers, Other End Users) and Geography
Interventional Neuroradiology Market Market Scope • The global interventional neuroradiology market accounted to US$ 1,969.39 Mn in 2018 and is expected to grow at a CAGR of 5.9% during the forecast period 2019 – 2027, to account to US$ 3,254.55 Mn by 2027. • The Asia Pacific interventional neuroradiology market is expected to grow at highest rate during the forecast period owing to prevalence of stroke and other neurological disorders along with the presence of supportive government initiatives and research in the field of neurology. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.
Interventional Neuroradiology Market MarketSegments
Interventional Neuroradiology Market Factors Contributing to MarketGrowth • Progressive Aging Population • Increasing Demand for Minimally Invasive Procedures • A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. Products such as neurovascular embolization and coiling assist devices including embolic coils, flow diversion devices and liquid embolic agents are widely being used in the field of neurology.
Interventional Neuroradiology Market Strategic Insights Strategic acquisition and product launches were observed as the most adopted strategy in global interventional neuroradiology industry. Few of the recent product launch and acquisitions are listed below;2018: Balt USA, subsidiary of Balt Extrusion, received 510 (k) approval for the Optima Coil System in the US. The approval of the Optima Coil System makes it the first Balt USA product to be developed and approved for use in the US.2018: MicroVention, Inc., received the FDA Premarket Approval (PMA) for the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms, which may account for up to 35% of all aneurysms.2016: Merit Medical Systems, Inc. received 510(k) clearance for the SwiftNINJA Steerable Microcatheter. The clearance aims to offer peripheral and coronary applications. With the exception of Japan, Merit has global distribution rights for the SwiftNINJA. For more details, get sample PDF copy: https://www.theinsightpartners.com/sample/TIPRE00003497/
Interventional Neuroradiology Market LeadingPlayers • Balt Extrusion • Merit Medical Systems • Terumo Corporation • Medtronic • Penumbra, Inc. • Stryker • DePuySynthes • Boston Scientific Corporation • W. L. Gore & Associates • MicroPort Scientific Corporation
“ A report titled “ Interventional Neuroradiology Market- Opportunities and Forecasts, 2019 – 2027 ” has been recently published by The Insight Partners. The report makes close observations of pipeline structure for end-to-end market around the world. It makes an in-depth analysis of current trends, drivers, and restraining factors that affect financial ratios relevant to the industry. Company profiles for key vendors in business builds a comprehensive picture of profitable opportunities from stakeholder’s perspective. ” To know more about the Interventional Neuroradiology Market - Opportunities and Forecasts, 2019– 2027report: https://www.theinsightpartners.com/reports/interventional-neuroradiology-market Follow uson ThankYou